溃疡性结肠炎合并IgA肾病1例
A Case Report of Ulcerative Colitis Complicated with IgA Nephropathy
DOI: 10.12677/acm.2025.1551418, PDF,   
作者: 孙莉娟, 彭 凯, 韩 越, 路艳艳*:青岛大学附属医院消化内科,山东 青岛
关键词: 炎症性肠病溃疡性结肠炎IgA肾病Inflammatory Bowel Disease Ulcerative Colitis IgA Nephropathy
摘要: 目的:通过1例病例报道分析一位溃疡性结肠炎合并IgA肾病的患者诊疗经过,从临床表现、内镜特点及肾组织学病理进行总结,增加对溃疡性结肠炎合并IgA肾病的认识。方法:报道溃疡性结肠炎合并IgA肾病1例。结果:患者在溃疡性结肠炎疾病治疗过程中,出现蛋白尿、血尿,行肾穿刺活检确诊IgA肾病,予以调整治疗溃疡性结肠炎药物,并加用肾保护药物,患者症状缓解,目前正在密切随访中。结论:炎症性肠病(IBD)与IgA肾病(IgAN)作为具有潜在关联的慢性炎症性疾病,其共同发病机制尚待阐明。本病例提示IBD患者应常规监测肾功能及尿常规等,两病在黏膜免疫、遗传易感性等层面的机制关联为靶向治疗提供新思路。
Abstract: Objective: To analyze the diagnosis and treatment process of a patient with ulcerative colitis complicated with IgA nephropathy through a case report, and summarize the clinical manifestations, endoscopic features and renal histopathology to enhance the understanding of ulcerative colitis complicated with IgA nephropathy. Methods: A case of ulcerative colitis complicated with IgA nephropathy was reported. Results: During the treatment of ulcerative colitis, the patient developed proteinuria and hematuria. Renal biopsy confirmed IgA nephropathy. The treatment for ulcerative colitis was adjusted and renal protective drugs were added. The patient’s symptoms were relieved and they are currently under close follow-up. Conclusion: Inflammatory bowel disease (IBD) and IgA nephropathy (IgAN) are chronic inflammatory diseases with potential associations. The common pathogenesis remains to be clarified. This case suggests that IBD patients should routinely monitor renal function and urine routine. The mechanism association between the two diseases at the levels of mucosal immunity and genetic susceptibility provides new ideas for targeted therapy.
文章引用:孙莉娟, 彭凯, 韩越, 路艳艳. 溃疡性结肠炎合并IgA肾病1例[J]. 临床医学进展, 2025, 15(5): 649-655. https://doi.org/10.12677/acm.2025.1551418

参考文献

[1] Xavier, R.J. and Podolsky, D.K. (2007) Unravelling the Pathogenesis of Inflammatory Bowel Disease. Nature, 448, 427-434. [Google Scholar] [CrossRef] [PubMed]
[2] Choi, J., Yu, C.H., Jung, H., Jung, M.K., Kim, Y., Cho, J., et al. (2012) A Case of Rapidly Progressive IgA Nephropathy in a Patient with Exacerbation of Crohn’s Disease. BMC Nephrology, 13, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[3] Oka, K., Nishimura, K., Kishikawa, H. and Ichikawa, Y. (2016) IgA1 Dominant Subclass of Latent IgA Mesangial Deposition in Donated Kidney. International Journal of Nephrology and Renovascular Disease, 9, 313-317. [Google Scholar] [CrossRef] [PubMed]
[4] 钟永忠, 殷佳珍, 汤绚丽, 李先法, 陈洪宇, 朱斌. 炎症性肠病肾损害的临床病理分析[J]. 中国现代医生, 2019, 57(34): 132-125.
[5] Mendoza, J.L., Lana, R., Taxonera, C., et al. (2005) Extraintestinal Manifestations in Inflammatory Bowel Disease: Differences between Crohn’s Disease and Ulcerative Colitis. Medical Clinics, 125, 297-300.
[6] Corica, D. and Romano, C. (2015) Renal Involvement in Inflammatory Bowel Diseases. Journal of Crohns and Colitis, 10, 226-235. [Google Scholar] [CrossRef] [PubMed]
[7] 冯云, 刘玉兰. 炎症性肠病的肠外表现的研究进展[J]. 胃肠病学和肝病学杂志, 2015, 24(6): 631-640.
[8] Annese, V. (2019) A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease. Saudi Journal of Medicine and Medical Sciences, 7, 66-73. [Google Scholar] [CrossRef] [PubMed]
[9] Ambruzs, J.M. and Larsen, C.P. (2018) Renal Manifestations of Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America, 44, 699-714. [Google Scholar] [CrossRef] [PubMed]
[10] 邹皓珍, 杨佳, 席哲帆, 纪瑞, 董华. IgA肾病发病机制及治疗新进展[J]. 中国医学创新, 2025, 22(7): 169-174.
[11] Takemura, T., Okada, M., Yagi, K., Kuwajima, H. and Yanagida, H. (2002) An Adolescent with IgA Nephropathy and Crohn Disease: Pathogenetic Implications. Pediatric Nephrology, 17, 863-866. [Google Scholar] [CrossRef] [PubMed]
[12] 范晶, 倪兆慧, 王玲. IgA肾病与炎症性肠病相关性的研究进展[J]. 中华肾脏病杂志, 2017, 33(11): 863-866.
[13] 李明, 司美君, 蔡凤姚, 余学清. IgA肾病研究的现状、问题与对策[J]. 实用医院临床杂志, 2024, 21(1): 1-4.
[14] Wu, M., Chen, C., Yiang, G., Cheng, P., Chen, Y., Chiu, H., et al. (2018) The Emerging Role of Pathogenesis of IgA Nephropathy. Journal of Clinical Medicine, 7, Article 225. [Google Scholar] [CrossRef] [PubMed]
[15] Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Müller-Newen, G. and Schaper, F. (2003) Principles of Interleukin (IL)-6-Type Cytokine Signalling and Its Regulation. Biochemical Journal, 374, 1-20. [Google Scholar] [CrossRef] [PubMed]
[16] Smith, A.C., Molyneux, K., Feehally, J. and Barratt, J. (2006) O-Glycosylation of Serum IgA1 Antibodies against Mucosal and Systemic Antigens in IgA Nephropathy. Journal of the American Society of Nephrology, 17, 3520-3528. [Google Scholar] [CrossRef] [PubMed]
[17] Robert, T., Berthelot, L., Cambier, A., Rondeau, E. and Monteiro, R.C. (2015) Molecular Insights into the Pathogenesis of IgA Nephropathy. Trends in Molecular Medicine, 21, 762-775. [Google Scholar] [CrossRef] [PubMed]
[18] Kett, K. and Brandtzaeg, P. (1987) Local IgA Subclass Alterations in Ulcerative Colitis and Crohn’s Disease of the Colon. Gut, 28, 1013-1021. [Google Scholar] [CrossRef] [PubMed]
[19] Forshaw, M.J., Guirguis, O. and Hennigan, T.W. (2005) IgA Nephropathy in Association with Crohn’s Disease. International Journal of Colorectal Disease, 20, 463-465. [Google Scholar] [CrossRef] [PubMed]
[20] Laufer, J. (2001) Extrahepatic Synthesis of Complement Proteins in Inflammation. Molecular Immunology, 38, 221-229. [Google Scholar] [CrossRef] [PubMed]
[21] Tortajada, A., Gutierrez, E., Pickering, M.C., Praga Terente, M. and Medjeral-Thomas, N. (2019) The Role of Complement in IgA Nephropathy. Molecular Immunology, 114, 123-132. [Google Scholar] [CrossRef] [PubMed]
[22] Li, M. and Yu, X. (2018) Genetic Determinants of IgA Nephropathy: Eastern Perspective. Seminars in Nephrology, 38, 455-460. [Google Scholar] [CrossRef] [PubMed]
[23] 曹辉, 刘素贤, 温红珠, 林江. 补体系统在炎症性肠病发病中的作用[J]. 现代免疫学, 2022, 42(6): 527-531.
[24] Oikonomou, K., Kapsoritakis, A., Eleftheriadis, T., Stefanidis, I. and Potamianos, S. (2011) Renal Manifestations and Complications of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 17, 1034-1045. [Google Scholar] [CrossRef] [PubMed]